Polymorphism of Prodynorphin promoter is associated with schizophrenia in Chinese population.

AIM To investigate the correlation between single nucleotide polymorphisms (SNPs) of functional candidate gene Prodynorphin (PDYN) and schizophrenia. METHODS SNPs in the promoter and exon regions of PDYN were screened and genotyped for association study in a cohort of Chinese Han schizophrenia cases and controls. RESULTS Two SNPs PDYN-1576C>T and PDYN-946C>G were identified in the promoter region but PDYN-946C>G showed significant differences of allele distribution (x2=6.15, P=0.013) and genotype distribution (x2=6.87, P=0.032) between schizophrenic and control subjects. CONCLUSION PDYN-946C>G polymorphism demonstrated an association with population susceptibility to schizophrenia.

[1]  J. Naranjo,et al.  Ca2+-dependent prodynorphin transcriptional derepression in neuroblastoma cells is exerted through DREAM protein activity in a kinase-independent manner , 2003, Molecular and Cellular Neuroscience.

[2]  M. Ventriglia,et al.  Allelic Variation in the Human Prodynorphin Gene Promoter and Schizophrenia , 2002, Neuropsychobiology.

[3]  R. Przewłocki,et al.  Effect of cocaine and amphetamine on biosynthesis of proenkephalin and prodynorphin in some regions of the rat limbic system. , 2002, Polish journal of pharmacology.

[4]  P. Robledo,et al.  Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice , 2001, The Journal of Neuroscience.

[5]  K. Reznikov,et al.  Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms. , 2001, Experimental cell research.

[6]  E Rauch,et al.  An Allelic Variation in the Human Prodynorphin Gene Promoter Alters Stimulus‐Induced Expression , 2000, Journal of neurochemistry.

[7]  J. Kleinman,et al.  Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects , 1997, Molecular Psychiatry.

[8]  Y. Hurd,et al.  Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain , 1996, Neuroscience.

[9]  R. Rimón,et al.  Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients , 1990, Psychiatry Research.

[10]  R. Webber,et al.  Lower CSF level of dynorphin(1–8) immunoreactivity in schizophrenic patients , 1985, Neuropeptides.

[11]  Y. Hurd,et al.  Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex , 2002, Molecular Psychiatry.

[12]  P. Robledo,et al.  Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  R. Nodar,et al.  Endogenous dynorphins: possible role in peripheral tinnitus. , 1999, The international tinnitus journal.

[14]  H. Akil,et al.  Molecular and Neuroanatomical Properties of the Endogenous Opioid System: Implications for Treatment of Opiate Addiction , 1997 .